{"organizations": [], "uuid": "8af3c686a121de4f02f38e7d4c17f30b1cab0c40", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180508.html", "section_title": "Archive News &amp; Video for Tuesday, 08 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-rockwell-medical-update-on-calcitr/brief-rockwell-medical-update-on-calcitriol-new-manufacturing-submission-to-fda-idUSASC0A0H5", "country": "US", "domain_rank": 408, "title": "BRIEF-Rockwell Medical Update On Calcitriol New Manufacturing Submission To FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.167, "site_type": "news", "published": "2018-05-08T20:45:00.000+03:00", "replies_count": 0, "uuid": "8af3c686a121de4f02f38e7d4c17f30b1cab0c40"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-rockwell-medical-update-on-calcitr/brief-rockwell-medical-update-on-calcitriol-new-manufacturing-submission-to-fda-idUSASC0A0H5", "ord_in_thread": 0, "title": "BRIEF-Rockwell Medical Update On Calcitriol New Manufacturing Submission To FDA", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "rockwell medical inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "bmission", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8 (Reuters) - Rockwell Medical Inc:\n* ROCKWELL MEDICAL UPDATE ON CALCITRIOL NEW MANUFACTURING SUBMISSION TO FDA\n* ROCKWELL MEDICAL INC - FOR CALCITRIOL VITAMIN D INJECTION, FDA HAS PROVIDED TARGET DATE FOR A RESPONSE TO SUBMISSION OF NO LATER THAN AUG 19, 2018\n* ROCKWELL MEDICAL - AWARE THAT FDA IS CONDUCTING PRE-APPROVAL INSPECTION OF CONTRACT MANUFACTURING ORGANIZATION’S (CMO’S) LAB PARTNER ON JUNE 25, 2018\n* ROCKWELL MEDICAL INC - STABILITY DATA THAT WAS PROVIDED IN CALCITRIOL SUBMISSION REMAINS WITHIN SPECIFICATION\n* ROCKWELL MEDICAL INC - FDA HAS CONFIRMED CALCITRIOL VITAMIN D INJECTION IS UNDER EXPEDITED REVIEW\n* ROCKWELL MEDICAL INC - NOW AWAITING FDA APPROVAL OF A NEW CONTRACT MANUFACTURER IN ORDER TO COMMERCIALIZE CALCITRIOL Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-08T20:45:00.000+03:00", "crawled": "2018-05-09T12:27:43.005+03:00", "highlightTitle": ""}